Sign In
Buy AVRO
$1.40
+0 (+0%)
At Close: Sep 19, 2024
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced a new development and commercialization ag
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an
May 02, 2020 (CDN Newswire via Comtex) --
A recent comprehensive study titled Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market 2020...
Avrobio (AVRO) Gets a Buy Rating from Mizuho Securities
08:05am, Tuesday, 28'th Apr 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on Avrobio (AVRO) today and set a price target of $35.00. The company's shares closed last
Avrobio (AVRO) Gets a Buy Rating from Mizuho Securities
08:05am, Tuesday, 28'th Apr 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on Avrobio (AVRO – Research Report) today and set a price
Is AVROBIO (AVRO) Stock a Solid Choice Right Now?
12:58pm, Tuesday, 14'th Apr 2020
AVROBIO (AVRO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVROBIO, Inc. - AVRO
06:26pm, Sunday, 12'th Apr 2020
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVROBIO, Inc. - AVRO
Stocks To Watch: OPEC Goes Virtual
01:04pm, Saturday, 04'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Analysts Offer Insights on Healthcare Companies: Avrobio (AVRO), Dicerna Pharma (DRNA) and Dar Bioscience (DARE)
03:47pm, Wednesday, 01'st Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avrobio (AVRO), Dicerna Pharma (DRNA) and Daré Bioscience
Analysts Offer Insights on Healthcare Companies: Avrobio (NASDAQ: AVRO), Dicerna Pharma (NASDAQ: DRNA) and Dar Bioscience (NASDAQ: DARE)
03:47pm, Wednesday, 01'st Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avrobio (
AVRO
–
Research Report
), Dicerna Pharma (
DRNA
–
Research Report
) and Daré Bioscience
Benzinga's Top Upgrades, Downgrades For March 31, 2020
01:34pm, Tuesday, 31'st Mar 2020
Upgrades * For Ultrapar Participacoes SA (NYSE: UGP), B of A Securities upgraded the stock from Neutral to Buy. For the fourth quarter, Ultrapar Participacoes had an EPS of \ No EPS Value , compared
AVROBIO Outlines Response to COVID-19 and Current Assessment of Business Impact
08:30pm, Monday, 30'th Mar 2020
AVROBIO, Inc. (Nasdaq:AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today shared an update on its response to the COVID-19 pand
uniQure to Participate in Multiple Upcoming Investor Conferences in April | MarketScreener
11:01am, Monday, 30'th Mar 2020Stocks To Watch: Investors Stay The Distance
01:04pm, Saturday, 28'th Mar 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
